IBDEI19D ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22580,0)
 ;;=64616^^132^1361^6^^^^1
 ;;^UTILITY(U,$J,358.3,22580,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22580,1,2,0)
 ;;=2^Chemodenerv Musc Neck Dyston
 ;;^UTILITY(U,$J,358.3,22580,1,3,0)
 ;;=3^64616
 ;;^UTILITY(U,$J,358.3,22581,0)
 ;;=64642^^132^1361^1^^^^1
 ;;^UTILITY(U,$J,358.3,22581,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22581,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 1-4
 ;;^UTILITY(U,$J,358.3,22581,1,3,0)
 ;;=3^64642
 ;;^UTILITY(U,$J,358.3,22582,0)
 ;;=64643^^132^1361^2^^^^1
 ;;^UTILITY(U,$J,358.3,22582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22582,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 1-4 Ea
 ;;^UTILITY(U,$J,358.3,22582,1,3,0)
 ;;=3^64643
 ;;^UTILITY(U,$J,358.3,22583,0)
 ;;=64644^^132^1361^3^^^^1
 ;;^UTILITY(U,$J,358.3,22583,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22583,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 5/> Mus
 ;;^UTILITY(U,$J,358.3,22583,1,3,0)
 ;;=3^64644
 ;;^UTILITY(U,$J,358.3,22584,0)
 ;;=64645^^132^1361^4^^^^1
 ;;^UTILITY(U,$J,358.3,22584,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22584,1,2,0)
 ;;=2^Chemodenerv 1 Extremity 5/> Ea
 ;;^UTILITY(U,$J,358.3,22584,1,3,0)
 ;;=3^64645
 ;;^UTILITY(U,$J,358.3,22585,0)
 ;;=64646^^132^1361^7^^^^1
 ;;^UTILITY(U,$J,358.3,22585,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22585,1,2,0)
 ;;=2^Chemodenerv Trunk Musc 1-5
 ;;^UTILITY(U,$J,358.3,22585,1,3,0)
 ;;=3^64646
 ;;^UTILITY(U,$J,358.3,22586,0)
 ;;=64647^^132^1361^8^^^^1
 ;;^UTILITY(U,$J,358.3,22586,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22586,1,2,0)
 ;;=2^Chemodenerv Trunk Musc 6/>
 ;;^UTILITY(U,$J,358.3,22586,1,3,0)
 ;;=3^64647
 ;;^UTILITY(U,$J,358.3,22587,0)
 ;;=J0585^^132^1361^9^^^^1
 ;;^UTILITY(U,$J,358.3,22587,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22587,1,2,0)
 ;;=2^OnabotulinumtoxinA 1 Unit
 ;;^UTILITY(U,$J,358.3,22587,1,3,0)
 ;;=3^J0585
 ;;^UTILITY(U,$J,358.3,22588,0)
 ;;=J0587^^132^1361^10^^^^1
 ;;^UTILITY(U,$J,358.3,22588,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22588,1,2,0)
 ;;=2^RimabotulinumtoxinB 100 Units
 ;;^UTILITY(U,$J,358.3,22588,1,3,0)
 ;;=3^J0587
 ;;^UTILITY(U,$J,358.3,22589,0)
 ;;=98925^^132^1362^1^^^^1
 ;;^UTILITY(U,$J,358.3,22589,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22589,1,2,0)
 ;;=2^OMT,1-2 Body Regions
 ;;^UTILITY(U,$J,358.3,22589,1,3,0)
 ;;=3^98925
 ;;^UTILITY(U,$J,358.3,22590,0)
 ;;=98926^^132^1362^2^^^^1
 ;;^UTILITY(U,$J,358.3,22590,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22590,1,2,0)
 ;;=2^OMT,3-4 Body Regions
 ;;^UTILITY(U,$J,358.3,22590,1,3,0)
 ;;=3^98926
 ;;^UTILITY(U,$J,358.3,22591,0)
 ;;=98927^^132^1362^3^^^^1
 ;;^UTILITY(U,$J,358.3,22591,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22591,1,2,0)
 ;;=2^OMT,5-6 Body Regions
 ;;^UTILITY(U,$J,358.3,22591,1,3,0)
 ;;=3^98927
 ;;^UTILITY(U,$J,358.3,22592,0)
 ;;=98928^^132^1362^4^^^^1
 ;;^UTILITY(U,$J,358.3,22592,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22592,1,2,0)
 ;;=2^OMT,7-8 Body Regions
 ;;^UTILITY(U,$J,358.3,22592,1,3,0)
 ;;=3^98928
 ;;^UTILITY(U,$J,358.3,22593,0)
 ;;=98929^^132^1362^5^^^^1
 ;;^UTILITY(U,$J,358.3,22593,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22593,1,2,0)
 ;;=2^OMT,9-10 Body Regions
 ;;^UTILITY(U,$J,358.3,22593,1,3,0)
 ;;=3^98929
 ;;^UTILITY(U,$J,358.3,22594,0)
 ;;=97762^^132^1363^1^^^^1
 ;;^UTILITY(U,$J,358.3,22594,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22594,1,2,0)
 ;;=2^C/O for Orthotic/Prosth Use
 ;;^UTILITY(U,$J,358.3,22594,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,22595,0)
 ;;=96116^^132^1363^2^^^^1
 ;;^UTILITY(U,$J,358.3,22595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22595,1,2,0)
 ;;=2^Neurobehavioral Status Exam,per hour
